News

Dr. Fiona Withey, Managing Director UK Clinical Services, first ever female executive to join the expert panel.

The Medical University of South Carolina and Bristol-Myers Squibb Company have announced that they have entered into a collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis.

Rubicon Genomics today announced it has secured $2 million in growth capital financing.

An investigational drug has been shown to reverse the anticoagulant effects of dabigatran in patients who present with bleeding or need for emergent surgery.

Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license.

Drug development and manufacturing contract to support toxicology studies for VR23.

Company opens new regional headquarters and clinical trial supply facility in Singapore.

Enhances Charles River Endotoxin and Microbial Detection’s position as the most comprehensive solution for rapid quality control testing.

Collaboration to crack difficult disease areas.